Format

Send to

Choose Destination
Circulation. 2018 Jan 16;137(3):307-309. doi: 10.1161/CIRCULATIONAHA.117.031678. Epub 2017 Oct 18.

Effect of Intravenous Fentanyl on Ticagrelor Absorption and Platelet Inhibition Among Patients Undergoing Percutaneous Coronary Intervention: The PACIFY Randomized Clinical Trial (Platelet Aggregation With Ticagrelor Inhibition and Fentanyl).

Author information

1
Ciccarone Center for the Prevention of Heart Disease (J.W.M., R.S.B.) jmcevoy1@jhmi.edu.
2
Division of Cardiology, Department of Medicine (J.W.M., K.I., R.K.H., M.J.C., A.R.K., J.A.B., M.C., C.-W.H., P.V.J., J.M.M., J.C.T., W.R.H., R.S.B., D.R.T., J.R.R., S.P.S.).
3
Johns Hopkins University School of Medicine, Baltimore, MD. Department of Epidemiology and the Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (J.W.M.).
4
Department of Pathology (T.S.K., W.A.C.).
5
Department of Medicine (R.R.G., T.P.G.).
6
Ciccarone Center for the Prevention of Heart Disease (J.W.M., R.S.B.).

KEYWORDS:

blood platelets; fentanyl; percutaneous coronary intervention; ticagrelor

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center